Although AD is multifactorial in nature, the accumulation of amyloid-beta (Aβ) peptides and tau protein in the nervous system has been strongly implicated in driving the progression of its symptoms, including cognitive decline and neuronal dysfunction (3, 4). This evidence concerns the gene MAPT and Alzheimer disease.